47 Hamilton Square
Birkenhead CH41 5AR
United Kingdom
44 1516 019 477
https://www.alterolabio.com
Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno:
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Timothy Paul Rogers | Executive Chairman & CFO | N/D | N/D | 1964 |
Mr. David John Hitchcock O.B.E. | CEO & Director | N/D | N/D | 1964 |
Mr. Colin G. Stott B.Sc. | COO & Director | N/D | N/D | 1966 |
Mr. Dominic Schiller | IP Counsel, Chief IP Officer & Director | N/D | N/D | 1965 |
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. Alterola Biotech, Inc. was founded in 2021 and is based in Birkenhead, the United Kingdom.
L'ISS Governance QualityScore di Alterola Biotech, Inc. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.